Technical Consultation On Determining Non Inferiority Of Vector Control Products Within An Established Class
Download Technical Consultation On Determining Non Inferiority Of Vector Control Products Within An Established Class full books in PDF, epub, and Kindle. Read online free Technical Consultation On Determining Non Inferiority Of Vector Control Products Within An Established Class ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : |
Publisher | : World Health Organization |
Total Pages | : 30 |
Release | : 2021-11-24 |
Genre | : Medical |
ISBN | : 9240038019 |
This meeting report describes the discussion and outcomes of the technical consultation on the value of non-inferiority assessments within the vector control evaluation process, for interventions that fall within an established intervention class. The discussion was based on pilot trials assessing non-inferiority of pyrethroid-PBO nets against malaria. Objectives of the meeting included determining the value, and challenges associated with using non-inferiority assessments and considerations of how these evaluations could be implemented within the existing framework of the WHO vector control evaluation process.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 62 |
Release | : 2023-09-12 |
Genre | : Medical |
ISBN | : 9240078657 |
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 36 |
Release | : 2024-05-16 |
Genre | : Medical |
ISBN | : 9240092749 |
The aim of this protocol is to support the conduct of entomological comparative efficacy assessments for vector control products and the associated non-inferiority analysis. This evidence is used to inform discussions within the guidelines development context as to whether a new vector control product should be considered as covered by one or more existing WHO recommendations or not. Alternatively, the evidence may inform the extension of an existing WHO recommendation or the development of a new one, provided that non-inferiority is demonstrated.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 25 |
Release | : 2022-11-30 |
Genre | : Medical |
ISBN | : 9240063307 |
Author | : |
Publisher | : World Health Organization |
Total Pages | : 21 |
Release | : 2021-05-21 |
Genre | : Medical |
ISBN | : 9240027351 |
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 22 |
Release | : 2024-02-21 |
Genre | : Medical |
ISBN | : 9240089640 |
On 30 October–1 November 2023, the WHO Malaria Policy Advisory Group (MPAG) convened to review updates and progress, and to provide guidance on thematic areas of work by the Global Malaria Programme. The meeting focused on the following topics: the Global Malaria Programme operational strategy 2024–2030; malaria vaccines R21/Matrix-M and RTS,S/AS01, the Malaria Vaccine Implementation Programme (MVIP) and status of malaria vaccine roll-out; guiding principles for prioritizing malaria interventions in resource-constrained settings to achieve maximum impact; progress and challenges on subnational tailoring of interventions; comparative effectiveness in the context of the arrival of new vector control products; the “High burden to high impact” (HBHI) approach; the WHO guidelines for malaria; antimalarial drug resistance in Africa; and the Mekong Malaria Elimination programme.
Author | : |
Publisher | : World Health Organization |
Total Pages | : 17 |
Release | : 2021-11-08 |
Genre | : Medical |
ISBN | : 9240038620 |
On 4–7 October 2021, the WHO Malaria Policy Advisory Group (MPAG) convened virtually to review updates and progress, and to provide guidance on thematic areas of work by the Global Malaria Programme. The meeting focused on 8 topics in 5 open sessions: 1) “Rethinking Malaria”; 2) update on the technical consultation on non-inferiority evaluations of vector control tools; 3) a discussion on malaria re-bound; 4) an update on antimalarial drug resistance in Africa; 5) an update on rectal artesunate (RAS) and quality of care; 6) a review of the relationship between chemoprevention and drug resistance; 7) an update on the WHO guidelines for malaria; and 8) a joint session with the Strategic Advisory Group of Experts on Immunization (SAGE) to review the evidence and consider a recommendation for broader use of the malaria vaccine.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 242 |
Release | : 2016-07-27 |
Genre | : Medical |
ISBN | : 9241549653 |
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes. It is an extension of earlier guidance and teaching material published by the World Health Organization (WHO): Handbook for integrated vector management Monitoring and evaluation indicators for integrated vector management Guidance on policy-making for integrated vector management and Core structure for training curricula on integrated vector management. The toolkit provides the technical detail required to plan implement monitor and evaluate an IVM approach. IVM can be used when the aim is to control or eliminate vector-borne diseases and can also contribute to insecticide resistance management. This toolkit provides information on where vector-borne diseases are endemic and what interventions should be used presenting case studies on IVM as well as relevant guidance documents for reference. The diseases that are the focus of this toolkit are malaria lymphatic filariasis dengue leishmaniasis onchocerciasis human African trypanosomiasis and schistosomiasis. It also includes information on other viral diseases (Rift Valley fever West Nile fever Chikungunya yellow fever) and trachoma. If other vector-borne diseases appear in a country or area vector control with an IVM approach should be adopted as per national priorities. Malaria as one of the most important vector-borne diseases in sub-Saharan Africa is the main focus of this document. Programmes targeting other vector-borne diseases can learn from the experiences gained from malaria vector control and presented here.
Author | : WHO Expert Committee on Biological Standardization. Meeting |
Publisher | : World Health Organization |
Total Pages | : 241 |
Release | : 2013 |
Genre | : Medical |
ISBN | : 9241209771 |
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and control of vaccines and other biologicals and the establishment of international biological reference materials. The report starts with a discussion of general issues brought to the attention of the Committee and provides information on the status and development of reference materials for various antibodies, antigens, blood products and related substances, cytokines, growth factors, endocrinological substances and in vitro diagnostic devices. The second part of the report, of particular relevance to manufacturers and national regulatory authorities, contains revised WHO recommendations for production and control of live attenuated influenza vaccines and for production and control of pneumococcal conjugate vaccines. New WHO guidelines on the regulatory evaluation of similar biotherapeutic medicines are also provided. Also included are a list of recommendations, guidelines and other documents for biological substances used in medicine, and of international standards and reference reagent for biological substances.
Author | : Council for International Organizations of Medical Sciences (CIOMS) |
Publisher | : World Health Organization |
Total Pages | : 0 |
Release | : 2017-01-31 |
Genre | : Bioethics |
ISBN | : 9789290360889 |
"In the new 2016 version of the ethical guidelines, CIOMS provides answers to a number of pressing issues in research ethics. The Council does so by stressing the need for research having scientific and social value, by providing special guidelines for health-related research in low-resource settings, by detailing the provisions for involving vulnerable groups in research and for describing under what conditions biological samples and health-related data can be used for research."--Page 4 de la couverture.